VALLOURECSA financials
VALLOURECSA
Country: FR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
969500P2Q1B47H4MCJ34 ISIN: FR0013506730 Financial statements
(EUR, as reported — unscaled; 102 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €4.03B | €5.11B |
| Depreciation & amortisation | €227.0M | €203.4M |
| Operating profit (EBIT) | €626.4M | €858.9M |
| Net finance income / (cost) | -€10.9M | -€66.1M |
| Profit before tax | €615.5M | €792.8M |
| Income tax expense | €143.0M | €269.0M |
| Profit for the year | €472.9M | €523.9M |
| — attributable to owners | €452.1M | €495.9M |
| — attributable to NCI | €20.8M | €28.0M |
| Total comprehensive income | €336.8M | €520.6M |
| Per share | ||
| Basic EPS | €2.00 | €2.20 |
| Diluted EPS | €1.90 | €2.10 |
| Cash flow statement | ||
| Net cash from operating activities | €487.6M | €694.9M |
| Net cash from investing activities | €70.7M | -€114.5M |
| Net cash from financing activities | -€403.0M | -€226.2M |
| Dividends paid | €2.2M | €4.5M |
| Proceeds from borrowings | €757.9M | €3.5M |
| Repayments of borrowings | €1.14B | €206.0M |
| Lease liability payments | €31.5M | €23.3M |
| Net change in cash | €155.3M | €354.2M |
| Balance sheet | ||
| Total assets | €5.53B | €5.71B |
| Non-current assets | €2.32B | €2.52B |
| Intangible assets & goodwill | €33.7M | €39.8M |
| Inventories | €1.17B | €1.24B |
| Trade & other receivables | €670.8M | €756.1M |
| Cash & equivalents | €1.10B | €899.9M |
| Total equity | €2.60B | €2.22B |
| — attributable to owners | €2.51B | €2.16B |
| Non-controlling interests | €88.9M | €67.0M |
| Non-current liabilities | €1.43B | €1.89B |
| Long-term borrowings | €962.1M | €1.35B |
| Trade & other payables | €795.0M | €762.5M |
| Deferred tax liabilities | €84.1M | €83.4M |
| Derived metrics | ||
| Operating margin | 15.5% | 16.8% |
| Net margin | 11.7% | 10.2% |
| Return on equity | 18.2% | 23.6% |
| Cash conversion ratio | 1.03× | 1.33× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €248.8M | €58.6M |
| Adjustments For Fair Value Gains Losses | €3.2M | €139.6M |
| Adjustments For Finance Income Cost | -€10.9M | -€66.1M |
| Adjustments For Income Tax Expense | €143.0M | €269.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€172.3M | -€49.9M |
| Adjustments For Provisions | -€214.4M | -€190.1M |
| Adjustments For Sharebased Payments | €41.3M | €17.6M |
| Adjustments For Undistributed Profits of Associates | €399.0K | €71.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.03B | €898.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €550.3M | €839.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€2.8M | €375.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €22.3M | €27.1M |
| Comprehensive Income Attributable To Owners of Parent | €314.5M | €493.5M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €3.21B | €3.20B |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €1.50B | €1.60B |
| Current Provisions | €83.5M | €249.4M |
| Deferred Tax Assets | €180.0M | €208.6M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €2.3M | €4.7M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€27.2M | -€2.8M |
| Equity and Liabilities | €5.53B | €5.71B |
| Gains Losses On Cash Flow Hedges Before Tax | -€64.6M | €12.4M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€91.5M | -€8.5M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €21.8M | -€144.9M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€13.8M | €782.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €544.0K | -€2.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €112.7M | €181.7M |
| Increase Decrease In Working Capital | -€112.4M | -€144.7M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €1.5M | €53.0K |
| Increase Decrease Through Sharebased Payment Transactions | €41.3M | €17.6M |
| Increase Decrease Through Treasury Share Transactions | €0 | €0 |
| Intangible Assets Other Than Goodwill | €33.1M | €42.0M |
| Interest Expense On Borrowings | €13.9M | €117.7M |
| Interest Income On Cash and Cash Equivalents | €34.6M | €29.5M |
| Interest Paid Classified As Operating Activities | €97.0M | €137.2M |
| Interest Received Classified As Operating Activities | €34.6M | €29.5M |
| Investment Accounted For Using Equity Method | €16.8M | €15.7M |
| Issue of Equity | €0 | €4.3M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €1.1M | €1.1M |
| Noncurrent Biological Assets | €61.2M | €69.7M |
| Noncurrent Provisions For Employee Benefits | €74.6M | €102.1M |
| Other Adjustments For Noncash Items | €17.3M | €4.9M |
| Other Comprehensive Income | -€136.1M | -€3.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €6.8M | -€6.5M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€50.8M | €11.6M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €6.2M | -€6.5M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€142.3M | €3.2M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €6.2M | -€6.5M |
| Other Current Financial Assets | €43.5M | €59.0M |
| Other Current Financial Liabilities | €158.1M | €95.8M |
| Other Current Nonfinancial Assets | €226.1M | €239.8M |
| Other Current Nonfinancial Liabilities | €324.9M | €369.6M |
| Other Expense By Function | €5.9M | €64.5M |
| Other Finance Income Cost | -€31.6M | €22.1M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €8.4M | €0 |
| Other Inflows Outflows of Cash Classified As Investing Activities | €29.2M | €18.1M |
| Other Longterm Provisions | €146.7M | €200.8M |
| Other Noncurrent Financial Assets | €70.7M | €74.2M |
| Other Noncurrent Financial Liabilities | €132.4M | €115.7M |
| Other Noncurrent Nonfinancial Assets | €78.9M | €85.1M |
| Other Noncurrent Nonfinancial Liabilities | €27.6M | €39.9M |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €0 | €0 |
| Profit Loss From Continuing Operations | €472.9M | €523.9M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €399.0K | €71.0K |
Methodology
Every line item above is a fact tagged in VALLOURECSA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.